Antihyperglycemic, hypolipidemic, hepatoprotective and antioxidative effects of dietary clove (Szyzgium aromaticum) bud powder in a high-fat diet/streptozotocin-induced diabetes rat model

Journal of the Science of Food and Agriculture

Volumn 94, Issue 13, 2014, Pages 2726-2737

  Adefegha, Stephen A ^a   Oboh, Ganiyu ^a   Adefegha, Omowunmi M ^b,c   Boligon, Aline A ^d   Athayde, Margareth L ^d  

^a FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b Federal College of Agriculture   (Nigeria)

^c UNIVERSITY OF IBADAN   (Nigeria)

^d FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Clove bud powder; High fat diet; Streptozotocin; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; LIPOTROPIC AGENT; PLANT MEDICINAL PRODUCT;

ADVERSE EFFECTS; AFRICAN MEDICINE; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; COMPLICATION; DIET SUPPLEMENTATION; DIET THERAPY; ENZYMOLOGY; ETHNOPHARMACOLOGY; EUGENIA; FLOWER; GROWTH, DEVELOPMENT AND AGING; LIPID DIET; LIVER; MALE; METABOLISM; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYTOTHERAPY; RANDOMIZATION; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; ETHNOPHARMACOLOGY; EUGENIA; FLOWERS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIPOTROPIC AGENTS; LIVER; MALE; MEDICINE, AFRICAN TRADITIONAL; NIGERIA; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT PREPARATIONS; RANDOM ALLOCATION; RATS, WISTAR;

RATTUS; SYZYGIUM AROMATICUM;

EID: 84906944920     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.6617     Document Type: Article

References (99)

1. Shaw JE, Sicree RA and Zimmet PZ, Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4-14 (2010).
2. Wild S, Sicree R, Roglic G, King H and Green A. 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053 (2004).
3. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 32:S62-S67 (2009).
4. Goldberg IJ, Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab 86:965-971 (2001).
5. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J and Schneider SH, Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40:418-423 (2002).
6. Yi X, Nickeleit V, James LR and Maeda N, α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy. J Diabetes Complicat 25:193-201 (2011).
7. Signorini AM, Fondelli C, Renzoni E, Puccetti C, Gragnoli G and Giorgi G, Antioxidant effects of gliclazide, glibenclamide, and metformin in patients with type 2 diabetes mellitus. Curr Ther Res 63:411-420 (2002).
8. Abou-Seif MA and Youssef A, Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 346:161-170 (2004).
9. Laight DW, Carrier MJ and Anggard EE, Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 47:457-464 (2000).
10. Nishikawa T, Edelstein D and Du XL, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790 (2000).
11. Brownlee M, Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820 (2001).
12. Cade WT, Diabetes-related microvascular and macrovascular diseases in the physical therapy. Phys Ther 88:1322-1335 (2008).
13. Karbach S, Jansen T, Horke S, Heeren T, Scholz A, Coldewey M et al., Hyperglycemia and oxidative stress in cultured endothelial cells--a comparison of primary endothelial cells with an immortalized endothelial cell line. J Diabetes Complicat 26:155-162 (2012).
14. Hill MF, Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants. Curr Cardiol Rev 4:259-268 (2008).
15. Goldstein BJ, Clinical translation of 'A Diabetes Outcome Progression Trial': adopt appropriate combination oral therapies in type 2 diabetes. J Clin Endocrinol Metabol 92:1226-1228 (2007).
16. Hao E, Tyrberg B, Itkin-Ansari P, Lakey JR, Geron I, Monosov EZ et al., Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med 12:310-316 (2006).
17. Friedman MA, Fleming LE, Fernandez M, Bienfang P, Schrank K, Dickey R et al., Ciguatera fish poisoning: treatment, prevention and management. Marine Drugs 6:456-479 (2008).
18. Willett W, Manson J, and Liu S, Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr 76:S274-S280 (2002).
19. Khan A, Safdar M, Khan MMA, Khattak KN and Anderson RA, Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26:3215-3218 (2003).
20. Kwon YI, Apostolidis E, Kim YC and Shetty K, Health benefits of traditional corn, beans and pumpkin: in vitro studies for hyperglycemia and hypertension management. J Med Food 10:266-275 (2007).
21. Gruenwald J, Freder J and Armbruester N, Cinnamon and health. Crit Rev Food Sci Nutr 50:822-834 (2010).
22. Ranilla LG, Kwon YI, Apostolidis E and Shetty K, Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour Technol 101:4676-4689 (2010).
23. Cheng DM, Kuhn P, Poulev A, Rojo LE, Lila MA and Raskin I, In vivo and in vitro antidiabetic effects of aqueous cinnamon extract and cinnamon polyphenol-enhanced food matrix. Food Chem 135:2994-3002 (2012).
24. McDougall GJ, Shpiro F, Dobson P, Smith P, Blake A and Stewart D, Different polyphenolic components of soft fruits inhibit α-amylase and α-glucosidase. J Agric Food Chem 53:2760-2766 (2005).
25. Cheplick S, Kwon Y, Bhowmik P and Shetty K, Phenolic-linked variation in strawberry cultivars for potential dietary management of hyperglycemia and related complications of hypertension. Bioresource Technol 101:404-413 (2010).
26. Oboh G, Akinyemi AJ, Ademiluyi AO and Adefegha SA, Inhibitory effects of aqueous extract of two varieties of ginger on some key enzymes linked to type-2 diabetes in vitro. J Food Nutr Res 49:14-20 (2010).
27. Adefegha SA and Oboh G, Inhibition of key enzymes linked to type-2 diabetes and sodium nitroprusside-induced lipid peroxidation in rat pancreas by water extractable phytochemicals from some tropical spices. Pharma Biol 50:857-865 (2012).
28. Sofowora A, Medicinal Plants and Traditional Medicine in Africa. Wiley, New York, pp. 1-20 (1984).
29. Sofowora A, Medicinal Plants and Traditional Medicine in Africa. Spectrum, Ibadan, pp. 55-71 (1993).
30. Odugbemi T, Outlines and Pictures of Medicinal Plants from Nigeria (1st edn). University of Lagos Press, Lagos, pp. 1-85 (2006).
31. Bailey CJ and Day C, Traditional plant medicines as treatment for diabetes. Diabetes Care 12:553-564 (1989).
32. Joshi BS and Kaul PN, Alternative medicine: herbal drugs and their critical appraisal. Part I. Prog Drug Res 56:1-76 (2001).
33. Erasto P, Adebola PO, Grierson DS and Afolayan AJ, An ethnobotanical study of plants used for the treatment of diabetes in Eastern Cape Province, South Africa. Afr J Biotechnol 4:1458-1460 (2005).
34. Afolayan AJ and Sunmonu TO, In vivo studies on antidiabetic plants used in South African herbal medicine. J Clin Biochem Nutr 47:98-106 (2010).
35. Zheng GQ, Kenney PM and Lam LK, Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. J Nat Prod 55:999-1003 (1992).
36. Huang Y, Ho SH, Lee HC and Yap YL, Insecticidal properties of eugenol, isoeugenol and methyleugenol and their effects on nutrition of Sitophilus zeamais Motsch. (Coleoptera: Curculionidae) and Tribolium castaneum (Herbst) (Coleoptera: Tenebrionidae). J Stored Prod Res 38:403-412 (2002).
37. Velluti A, Sanchis V, Ramos AJ and Marín, S, Inhibitory effect of cinnamon, clove, lemongrass, oregano and palmarose essential oils on growth and fumonisin B1 production by Fusarium proliferatum in maize grain. Int J Food Microbiol 89:145-154 (2003).
38. Lee KG and Shibamoto T, Antioxidant property of aroma extract isolated from clove buds [Syzygium aromaticum (L.) Merr. et Perry]. Food Chem 74:443-448 (2001).
39. Ngubane PS, Masola B and Musabayane CT, The effects of Syzygium aromaticum- derived oleanolic acid on glycogenic enzymes in streptozotocin-induced diabetic rats. Renal Failure 33:434-439 (2011).
40. Kuroda M, Mimaki Y, Ohtomo T, Yamada J, Nishiyama T, Mae T et al., Hypoglycemic effects of clove (Syzygium aromaticum flower buds) on genetically diabetic KK-Ay mice and identification of the active ingredients. J Nat Med 66:394-399 (2012).
41. Prasad RC, Herzog B, Boone B, Sims L and Waltner-Law M, An extract of Syzygium aromaticum represses genes encoding hepatic gluconeogenic enzymes. J Ethnopharmacol 96:295-301 (2005).
42. Atawodi SE, Atawodi JC, Pfundstein B, Spiegelhalder B, Bartsch H and Owen R, Assessment of the polyphenol components and in vitro antioxidant properties of Syzygium aromaticum (L.) Merr. & Perry. Elect J Environ Agric Chem 10:1970-1978 (2011).
43. 2+- induced lipid peroxidation in rat pancreas. Asian Pac J Trop Biomed 2:774-781 (2012).
44. Oboh G and Ogunruku OO, Cyclophosphamide-induced oxidative stress in brain: protective effect of hot short pepper (Capsicum frutescens L. var. abbreviatum). Exp Toxicol Pathol 62:227-233 (2010).
45. Srinivasan K, Viswanad B, Asrat L, Kaul CL and Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type-2 diabetes and pharmacological screening. Pharmacol Res 52:313-320 (2005).
46. Worthington V, Alpha amylase, in Worthington Enzyme Manual, ed. by Worthington K and Worthington V. Worthington Biochemical Corp., Freehold, NJ, pp. 36-41 (1993).
47. Apostolidis E, Kwon YI and Shetty K. Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innov Food Sci Emerg Technol 4:46-54 (2007).
48. 48.Cushman DW and Cheung HS. Spectrophotometric assay and properties of the Angiotensin I converting enzyme of rabbit lung. Biochem Pharmacol 20:1637-1648 (1971).
49. Reitman S and Frankel SA, Colorimetric method for the determination of serum level of glutamate-oxaloacetate and pyruvate transaminases. Am J Clin Pathol 28:56-63 (1957).
50. Klen B, Read PA and Babson LA, Rapid method for the quantitative determination of serum alkaline phosphatase. Clin Chem 6:269-275 (1960).
51. Lowry OH, Rosenbrough NJ, Farr AL and Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 193:265-270 (1951).
52. Jollow DJ, Mitchell JR, Zampaglione N and Gillete JR. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3, 4 bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11:151-169 (1974).
53. Habig WH, Pabst MJ, Jacoby WB. Glutathione-S-transferases: the first enzymatic step in mercaptoric acid formation. J Biol Chem 249:7130-7139 (1974).
54. Ohkawa H, Ohishi N and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358 (1979).
55. Asru KS, Colorimetric assay of catalase. Anal Biochem 47:389-394 (1972).
56. Lawerence RA and Burk RF, Glutathione peroxidase activity in selenium-deficient rat's liver. Biochem Biophys Res Commun 71:952-958 (1961).
57. Misra HP and Fridovich I, The generation of superoxide radical during the antioxidant of hemoglobin. J Biol Chem 247:6960-6962 (1972).
58. Sabir SM, Ahmad SD, Hamid A, Khan MQ, Athayde ML, Santos DB et al., Antioxidant and hepatoprotective activity of ethanolic extract of leaves of Solidago microglossa containing polyphenolic compounds. Food Chem 131:741-747 (2012).
59. International Conference on Harmonization (ICH) of Technical Requirement for the Registration of Pharmaceutics for Human use 'Validation of Analytica procedures: Text and Methodology. ICH Q2 (R1). Geneva (November 2005).
60. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM et al., A new rat model of Type-2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49:1390-1394 (2000).
61. Qureshi AA, Crenshaw TD, Abuirmeileh N, Peterson DM and Elson CE, Influence of minor plant constituents on porcine hepatic lipid metabolism: impact on serum lipid. Atherosclerosis 64:109-115 (1987).
62. Martínez IM, Morales I, Garcia-Pino G, Campillo JE and Tormo MA, Experimental type-2 diabetes induces enzymatic changes in isolated rat enterocytes. Exp Diabesity Res 4:119-123 (2003).
63. Rajasekaran FK, Sivagnanam KR and Subramanian S, Hypoglycemic effect of Aloe vera gel on streptozotocin-induced diabetes in experimental rats. J Med Food 7:61-66 (2004).
64. Tormo MA, Gil-Exojo I, Romero de Tejada A and Campillo JE, White bean amylase inhibitor administered orally reduces glycaemia in type-2 diabetic rats. Br J Nutr 96:539-544 (2006).
65. Lee SK, Hwang JY, Kang MJ, Kim YM, Jung SH, Lee JH et al., Hypoglycemic effect of onion skin extract in animal models of diabetes mellitus. Food Sci Biotechnol 17:130-134 (2008).
66. Méndez JD, De-Haro R, Méndez-Valenzuela V, Ble-Castillo JL and Rubio HO, Altered pancreatic arginase activity and α-amylase levels in patients with type-2 diabetes and alcoholic pancreatitis. Adv Environ Biol 3:113-119 (2009).
67. Kim SH, Jo SH, Kwon YI and Hwang JK, Effects of onion (Allium cepa L.) extract administration on intestinal α-glucosidases activities and spikes in postprandial blood glucose levels in rats model. Int J Mol Sci 12:3757-3569 (2011).
68. Wu B, Basu S, Meng S, Wang X, Zhang S and Hu M, Regioselective sulfation and glucuronidation of phenolics: Insights into the structural basis of conjugation. Curr Drug Metab 12:900-916 (2011).
69. Adisakwattana S, Lerdsuwankij O, Poputtachai U, Minipun A and Suparpprom C, Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal α-glucosidase and pancreatic α-amylase. Plant Foods Hum Nutr 66:143-148 (2011).
70. Je J, Park P, Kim E and Ahn C, Antioxidant and angiotensin I-converting enzyme inhibitory activity of Bambusae caulis in Liquamen. Food Chem 113:932-935 (2009).
71. Ekor M, Odewabi AO, Kale OE, Oritogun KS, Adesanoye OA and Bamidele TO, Pharmacologic inhibition of renin-angiotensin system did not attenuate hepatic toxicity induced by carbon tetrachloride in rats. Hum Exp Toxicol 30:1840-1848 (2011).
72. Hosseini M, Shafiee SM and Baluchnejadmojarad T, Garlic extract reduces serum angiotensin converting enzyme (ACE) activity in nondiabetic and streptozotocin-diabetic rats. Pathophysiology 14:109-112 (2007).
73. Kusunoki J, Aragane K, Kitamine T, Kozono H, Kano K, Fujinami K et al., Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme a: cholesterol acyltransferase activity. Arterioscl Thromb Vasc Biol 20:171-178 (2000).
74. Shafrir E, Diabetes in animals: contribution to the understanding of diabetes by study of its etiopathology in animal models, in Diabetes Mellitus, ed. by Porte D, Sherwin RS and Baron A. McGraw-Hill, New York, pp. 231-255 (2003).
75. Veerapur VP, Prabhakar KR, Thippeswamy BS, Bansal P, Srinivasan KK and Unnikrishnan MK, Antidiabetic effect of Ficus racemosa Linn. stem bark in high-fat diet and low-dose streptozotocin-induced Type-2 diabetic rats: a mechanistic study. Food Chem 132:186-193 (2012).
76. Navarro VJ and Senior JR, Drug related hepatotoxicity. New Engl J Med 354:731-739 (2006).
77. Kaplan MM, Serum alkaline phosphatase: another piece is added to the puzzle. Hepatology 6:526-528 (1986).
78. Guven A, Yavuz O, Cam M, Ercan F, Bukan N, Comunoglu C et al., Effects of melatonin on streptozotocin-induced diabetic liver injury in rats. Acta Histochem 108:85-93 (2006).
79. Singh SK, Rai PK, Mehta S, Singh RK and Watal G, Curative effect of Cynodon dactylon against STZ induced hepatic injury in diabetic rats. Ind J Clin Biochem 24:410-413 (2009).
80. Zafar M, Naeem-Ul-Hassan NS, Ahmed M and Kaimkhani ZA, Altered liver morphology and enzymes in streptozotocin induced diabetic rats. Int J Morphol 27:719-725 (2009).
81. Ceriello A, Postprandial hyperglycemia and cardiovascular disease. Diabetes Care 32:521-522 (2009).
82. Dix TA and Aikens J, Mechanisms and biological relevance of lipid peroxidation initiation. Chem Res Toxicol 6:2-18 (1993).
83. Avis TJ, Michaud M and Tweddell RJ, Role of lipid composition and lipid peroxidation in the sensitivity of fungal plant pathogens to aluminum chloride and sodium metabisulfite. Appl Environ Microbiol 73:2820-2824 (2007).
84. Xie Y, Zhang Y, Zhang L, Zeng S, Guo Z and Zheng B, Protective effects of alkaloid compounds from Nelumbinis Plumula on tert-butyl hydroperoxide-induced oxidative stress. Molecules 18:10285-10300 (2013).
85. Aruoma IO, Free radicals, oxidative stress, and antioxidants in human health and disease. J Am Oil Chem Soc 75:199-212 (1998).
86. De Haan, JB, Cristiano F, Iannello R, Bladier C, Kelner MJ and Kola I, Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Hum Mol Genet 5:283-292 (1996).
87. Cohen G and Heikkila RE, The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biochem 249:2447-2452 (1994).
88. Lim CY, Junit SM, Abdulla MA and Aziz AA, In vivo biochemical and gene expression analyses of the antioxidant activities and hypocholesterolaemic properties of Tamarindus indica fruit pulp extract. PLoS ONE 8: e70058, doi:10.1371/journal.pone.0070058 (2013).
89. Hayes JD and Pulford DJ, The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445-600 (1995).
90. Sies H, Glutathione and its role in cellular functions. Free Radic Biol Med 27:916-921 (1999).
91. Anderson ME, Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact 111:1-14 (1998).
92. Townsend DM, Tew KD and Tapiero H, The importance of glutathione in human disease. Biomed Pharmacother 57:145-155 (2003).
93. Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH et al., Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr 22:18-35 (2003).
94. Li X, Qu ZC and May JM, GSH is required to recycle ascorbic acid in cultured cell lines. Antioxid Red Signal 3:1089-1097 (2001).
95. Shan B, Cai YZ, Sun M and Corke H, Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J Agric Food Chem 53:7749-7759 (2005).
96. Wojdylo A, Oszmianski J and Czemerys R, Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem 105:940-949 (2007).
97. Lu M, Yuan B, Zeng M and Chen J, Antioxidant capacity and major phenolic compounds of spices commonly consumed in China. Food Res Int 44:530-536 (2011).
98. Scalbert A, Manach C, Morand C and Remesy C. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287-306 (2005).
99. Passamonti S, Terdoslavich M, Franca R, Vanzo A, Tramer F, Braidot E et al., Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Cur Drug Metab 10:369-394 (2009).